REQUEST A DEMO
Total
USD $0.00
Search more companies

Actelion Pharmaceuticals do Brasil Ltda. (Brazil)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Architectural, Engineering, and Related Services | Research and Development in the Physical, Engineering, and Life Sciences | Corporate, Subsidiary, and Regional Managing Offices
Full name: Actelion Pharmaceuticals do Brasil Ltda. Profile Updated: October 18, 2023
Buy our report for this company USD 9.95 Available in: English & Portuguese Download a sample report

Actelion Pharmaceuticals Do Brasil Ltda. is headquartered in Rio de Janeiro, RJ. Actelion do Brasil is a subsidiary of Actelion, a multinational company with more than 30 branches in activity in countries such as the United States, Canada, Switzerland and in several member States of the European Union. Actelion is a biopharmaceutical company focused on the discovery, development and commercialization of pharmaceuticals for medical needs that are unmet by the industry.

Headquarters
R Dalcidio Jurandir, 255, Commercial Office, Barra Da Tijuca
Rio de Janeiro; Rio de Janeiro; Postal Code: 22631-250

Contact Details: Purchase the Actelion Pharmaceuticals do Brasil Ltda. report to view the information.

Basic Information
Total Employees:
Purchase the Actelion Pharmaceuticals do Brasil Ltda. report to view the information.
Registered Capital:
Purchase the Actelion Pharmaceuticals do Brasil Ltda. report to view the information.
Financial Auditors:
Purchase the Actelion Pharmaceuticals do Brasil Ltda. report to view the information.
Incorporation Date:
August 13, 2002
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?